Richard Pye has been appointed as chief financial officer and executive director at clinical AI technology company Sensyne Health.
He was previously Sensyne’s chief investment officer.
Michael Norris, Sensyne’s interim CFO, and Geoff Race, co-founder and CFO of Minerva Neurosciences, have joined the Sensyne board as non-executive directors.
Sir Bruce Keogh, chair of Sensyne Health, said: “I am delighted to welcome Richard, Geoff and Michael to the board of Sensyne. I would like to thank Michael for his excellent service as interim CFO and I am delighted he has agreed to stay with the business as a non-executive director. These senior appointments, combined with our strong team, will help us boost commercial momentum and accelerate the scaling of the business internationally.”
Related Posts
-
March 28, 2022
Mirko Bianchi, Keyu Jin and Amanda Norton have been nominated for election as non-executive members of the Credit Suisse board.
-
April 13, 2022
Lisa Hook, Thomas Saueressig and Kai Öistämö have been elected to the Nokia board following the company AGM last week.
-
December 19, 2017
The average age of UK non-executive directors has risen to 60.3 years, topping 60 for the first time; and while more women occupy boardroom positions, there are still very few female chairs.
-
March 31, 2021
Juliet Thompson, Joanna Le Couilliard, Mark Stejbach and Jerome Lande have taken board roles at the pharmaceutical firm.